Polyadenylation and control of neuroendocrine gene expression

Frontiers of Hormone Research

Volumn 25, Issue , 1999, Pages 122-140

  Santra, Bidisha ^a   Carter, David A ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; MESSENGER RNA; POLYADENOSINE; POLYADENYLIC ACID; POLYMER; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL; CHEMISTRY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; NEUROSECRETION; REVIEW; RNA SPLICING; UNTRANSLATED REGION;

ADENOSINE; ANIMALS; GENE EXPRESSION REGULATION; HUMANS; NEUROSECRETORY SYSTEMS; POLY A; POLYMERS; RNA SPLICING; RNA, MESSENGER; TRANSCRIPTION, GENETIC; UNTRANSLATED REGIONS; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0033287238     PISSN: 03013073     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000060999     Document Type: Article

References (66)

1. Lim L, Canelakis E: Adenine-rich polymer associated with reticulocyte messenger RNA. Nature 1970;227:710-712.
2. Baker EJ: Control of poly (A) tail length; in Brawerman G (ed): Control of Messenger RNA Stability. London, Academic Press, 1993, pp 367-415.
3. Lewis JD, Gunderson SI, Mattaj IW: The influence of 5′ and 3′ end structures on pre-mRNA metabolism. J Cell Sci 1995;S19:13-19.
4. Wahle E: 3′-End cleavage and polyadenylation of mRNA precursors. Biochim Biophys Acta 1995;1261:183-194.
5. Foulkes NS, Schlotter F, Pevet P, Sassone-Corsi P: Pituitary-hormone FSH directs the CREM functional switch during spermatogenesis. Nature 1993;362:264-267.
6. Sheflin LG, Brooks EM, Keegan BP, Spaulding SW: The cytosolic 47-kilodalton protein that binds to the 3′-untranslated region of epidermal growth-factor transcripts responds to orchiectomy in a tissue-specific fashion. Endocrinology 1996;137:5616-5623.
7. Chew LJ, Murphy D, Carter DA: Differential use of 3′ poly (A) addition sites in vasoactive intestinal peptide messenger ribonucleic acid of the rat anterior pituitary gland. J Neuroendocrinol 1991;3:351-355.
8. Chew LJ, Murphy D, Carter DA: Alternatively polyadenylated vasoactive intestinal peptide mRNAs are differentially regulated at the level of stability. Mol Endocrinol 1994;8:603-613.
9. Chew LJ, Seah V, Murphy D, Carter DA: Anterior pituitary vasoactive intestinal peptide mRNA is colocalized with prolactin mRNA in hyperoestrogenised rats. J Mol Endocrinol 1996;16:211-220.
10. Chew LJ, Burke ZD, Morgan H, Gozes I, Murphy D, Carter DA: Transcription of the vasoactive intestinal peptide gene in response to glucocorticoids: Differential regulation of a labile protein in rat anterior pituitary. Mol Cell Endocrinol 1997;130:83-91.
11. Levy JR, Hug V: Regulation of insulin receptor gene expression: Cell cycle-mediated effects on insulin receptor mRNA stability. J Biol Chem 1992;267:25289-25295.
12. Mountford PS, Brandon MR, Adams TE: Removal of 3′ untranslated sequences dramatically enhances transient expression of ovine follicle-stimulating hormone expression beta messenger ribonucleic acid. J Neuroendocrinol 1992;4:655-658.
13. Brewer G: An A+U-rich element RNA-binding factor regulates c-myc stability in vitro. Mol Cell Biol 1991;11:2460-2466.
14. Wisdom R, Lee W: The protein coding region of c-myc mRNA contains a sequence that specifies mRNA turnover and induction by protein synthesis inhibitors. Genes Dev 1991;5:232-243.
15. de Sauvage F, Kruys V, Marinx O, Huez G, Octave JN: Alternative polyadenylation of the amyloid protein precursor mRNA regulates translation. EMBO J 1992;11:3099-3103.
16. Jackson RJ, Standart N: Do the poly (A) tail and 3′ untranslated region control mRNA translation? Cell 1990;62:15-24.
17. Vassalli JD, Huarte J, Belin D, Gubler P, Vassalli A, O'Connell ML, Parton LA, Rickles RR, Strickland S: Regulated polyadenylation controls mRNA translation during meiotic maturation of mouse oocytes. Genes Dev 1989;3:2163-2171.
18. Wickens M: In the beginning is the end: Regulation of poly (A) addition and removal during early development. TIBS 1990;15:320-324.
19. Muckenthaler M, Gunkel N, Stripecke R, Hentze MW: Regulated poly (A) tail shortening in somatic cells mediated by cap-proximal repressor proteins and ribosome association. RNA 1997;3:983-995.
20. Rubin HN, Halim MN: Why, when and how does the poly (A) tail shorten during mRNA translation. Int J Biochem 1993;25:287-295.
21. Decker CJ, Parker R: Mechanisms of mRNA degradation in eukaryotes. TIBS 1994;19:336-340.
22. Wilson T, Treisman R: Removal of poly (A) and consequent degradation of c-fos mRNA facilitated by 3′ AU-rich sequences. Nature 1998;336:396-399.
23. Shyu AB, Greenberg ME, Belasco JG: Two distinct destabilizing elements in the c-fos message trigger deadenylation as a first step in rapid mRNA decay. Genes Dev 1991;5:221-231.
24. Couttet P, Fromont Racine M, Steel D, Pictet R, Grange T: Messenger RNA deadenylation precedes decapping in mammalian cells. Proc Natl Acad Sci USA 1997;94:5628-5633.
25. Paek I, Axel R: Glucocorticoids enhance stability of growth hormone mRNA. Mol Cell Biol 1987;7:1496-1507.
26. Cochrane AW, Deely RG: Estrogen-dependent activation of the avian very lowdensity apolipoprotein II and vitellogenin genes: Transient alterations in mRNA polyadenylation and stability during induction. J Mol Biol 1988;203:555-567.
27. Sheflin LG, Brooks EM, Keegan BP, Spaulding SW: Assessment of transcript polyadenylation by 3′ race: The response of epidermal growth-factor messenger-ribonucleic-acid to thyroid-hormone in the thyroid and submaxillary-glands. Endocrinology 1995;136:5666-5676.
28. Sheflin LG, Brooks EM, Keegan BP, Spaulding SW: Increased epidermal growth-factor expression produced by testosterone in the submaxillary gland of female mice is accompanied by changes in poly-A tail length and periodicity. Endocrinology 1996;137:2085-2092.
29. Murphy D, Pardy K, Seah V, Carter DA: Posttranscriptional regulation of rat growth hormone gene expression: Increased message stability and nuclear polyadenylation accompany thyroid hormone depletion. Mol Cell Biol 1992;12:2624-2632.
30. Shah GN, Giddings SJ, Mooradian AD: Shortening of poly(A) tail of glucose transporter - One mRNA in experimental diabetes mellitus. Brain Res 1997;754:213-220.
31. Eckner R, Ellmeier W, Birnstiel ML: Mature mRNA 3′ end formation stimulates RNA export from the nucleus. EMBO J 1991;10:3513-3522.
32. Murphy D, Funkhouser J, Ang H-L, Foo N-C, Carter D: Extrahypothalamic expression of the vasopressin and oxytocin genes. Ann NY Acad Sci 1993;689:91-106.
33. Murphy D, Levy A, Lightman S, Carter D: Vasopressin RNA in the neural lobe of the pituitary: Dramatic accumulation in response to salt-loading. Proc Natl Acad Sci USA 1989;86:9002-9005.
34. Carrazana EJ, Paseka KB, Majzoub JA: The vasopressin mRNA poly(A) tract is unusually long and increases during stimulation of vasopressin gene expression in vivo. Mol Cell Biol 1988;8:2267-2274.
35. Zingg HH, Lefebvre DL, Almazan G: Regulation of poly(A) tail size of vasopressin mRNA. J Biol Chem 1988;263:11041-11043.
36. Carter DA, Murphy D: Rapid changes in poly (A) tail length of vasopressin and oxytocin mRNAs form a common early component of neurohypophyseal peptide gene activation following physiological stimulation. Neuroendocrinology 1991;53:1-6.
37. Chaturvedi CM, Zheng Z, Shimada K, Cornett LE, Koike TI: Changes in poly(A) tail length of arginine vasotocin messenger ribonucleic-acid in the hypothalamus of water-deprived chicken. Gen Comp Endocrinol 1996;103:316-322.
38. Emanuel RL, Girard DM, Thull DL, Majzoub JA: Regulated expression of vasopressin gene by cAMP and phorbol ester in primary rat fetal hypothalamic cultures. Mol Cell Endocrinol 1992;86:29-36.
39. Murphy D, Carter DA: Vasopressin gene expression in the rodent hypothalamus: Transcriptional and posttranscriptional responses to physiological stimulation. Mol Endocrinol 1990;4:1051-1059.
40. Fehr S, Schmale H, Richter D: Differential polyadenylation of the mutant vasopressin mRNA during development of brattleboro rats. Biochem Biophys Res Commun 1989;158:555-561.
41. Rehbein M, Richter D: Poly(A) tail length of oxytocin- and lysine vasopressin-encoding mRNAs increases during development in the porcine hypothalamus. J Mol Endocrinol 1989;4:151-158.
42. Chooi KF, Carter DA, Murphy D: Decrease in hypothalamic vasopressin mRNA poly(A) tail length following physiological stimulation. Cell Mol Neurobiol 1992;12:557-567.
43. Mohr E, Fehr S, Richter D: Axonal transport of neuropeptide encoding mRNAs within the hypothalamo-neurohypophyseal tract of rats. EMBO J 1991;10:2419-2424.
44. Carter DA, Murphy D: Regulation of vasopressin gene expression in the bed nucleus of the stria terminalis: Gonadal steroid dependent changes in vasopressin mRNA are associated with alterations in mRNA poly (A) tail length but are independent of the rate of vasopressin gene transcription. J Neuroendocrinol 1993;5:509-515.
45. Vercaeren I, Winderickx J, Devos A, Peeters B, Heyns W: An effect of androgens on the length of the poly(A)-tail and alternative splicing cause size heterogeneity of the messenger ribonucleic acids encoding cystatin-related protein. Endocrinology 1992;131:2469-2502.
46. Robinson BG, Frim BG, Schwartz WJ, Majzoub JA: Vasopressin mRNA in the suprachiasmatic nuclei: Daily regulation of polyadenylate tail length. Science 1988;241:342-344.
47. Carter DA, Murphy M: Diurnal rhythm of vasopressin mRNA species in the rat suprachiasmatic nucleus: Independence of neuroendocrine modulation and maintenance in explant culture. Mol Brain Res 1989;6:233-239.
48. Carter DA, Murphy D: Nuclear mechanisms mediate rhythmic changes in vasopressin mRNA expression in the rat suprachiasmatic nucleus. Mol Brain Res 1991;12:315-321.
49. Zingg HH, Lefebvre DL: Oxytocin mRNA: Increase of polyadenylate tail size during pregnancy and lactation. Mol Cell Endocrinol 1989;65:59-62.
50. Zingg HH, Lefebvre DL: Oxytocin and vasopressin gene expression during gestation and lactation. Mol Brain Res 1988;4:1-6.
51. Mellon PL, Windle JJ, Goldsmith PC, Padula CA, Roberts JL, Weiner RL: Immortalization of hypothalamic Gn-RH neurons by genetically targeted tumorigenesis. Neuron 1990;5:1-10.
52. Gore AC, Yeo TT, Ho A, Roberts JL: Post-transcriptional regulation of the gonadotropin-releasing hormone gene in GT1-7 cells. J Neuroendocrinol 1997;4:271-277.
53. Adler GK, Rosen LB, Fiandaca MJ, Majzoub JA: Protein kinase-C activation increases the quantity and poly(A) tail length of corticotropin-releasing hormone messenger RNA in NPLC cells. Mol Endocrinol 1992;6:476-484.
54. Weiss J, Crowley WF, Jameson JL: Pulsatile gonadotropin-releasing-hormone modifies polyadenylation of gonadotropin subunit messenger ribonucleic acids. Endocrinology 1992;130:415-420.
55. Bouamoud N, Lerrant Y, Ribot G, Counis R: Differential stability of messenger-RNAs coding for alpha-subunits and gonadotropin beta-subunits in cultured rat pituitary cells. Mol Cell Endocrinol 1992;88:143-151.
56. Carter DA, Chew LJ, Murphy D: In vitro regulation of rat prolactin messenger ribonucleic acid poly(A) tail length: Modulation by bromocriptine. J Neuroendocrinol 1993;5:201-204.
57. Krane IM, Spindel ER, Chin WW: Thyroid hormone decreases the stability and the poly(A) tract length of rat thyrotropin b-subunit messenger RNA. Mol Endocrinol 1991;5:469-475.
58. Chen-Kiang S, Lavery DJ: Preparation of precursors to mRNA from mammalian cell nuclei. Methods Enzymol 1989;180:69-81.
59. Waller SJ, Carter DA, Ang HL, Ho MY, Zeng Q, Murphy D: Regulation of the extent of polyadenylation of vasopressin and growth hormone mRNAs in response to physiological stimuli. Regul Pept 1993;45:37-41.
60. Rao MN, Chernokalskaya E, Schoenberg DR: Regulated nuclear polyadenylation of xenopus albumin pre-messenger-RNA. Nucl Acids Res 1996;24:4078-4083.
61. Wahle E: Poly(A) tail length control is caused by terminatin of processive synthesis. J Biol Chem 1995;270:2800-2808.
62. Carter DA, Murphy D: Independent regulation of neuropeptide mRNA level and poly (A) tail length. J Biol Chem 1988;264:6601-6603.
63. Carter DA, Murphy D: Vasopressin mRNA in parvocellular neurones of the rat suprachiasmatic nucleus exhibits increased poly(A) tail length following water deprivation. Neurosci Lett 1990;109:180-185.
64. Grant FD, Reuventos J, Gordon JW, Kawabata S, Miller M, Majzoub JA: Expression of the arginine-vasopressin gene in transgenic mice. Mol Endocrinol 1993;7:659-667.
65. Zeng Q, Carter DA, Murphy D: Cell specific expression of a vasopressin transgene in rats. J Neuroendocrinol 1994;6:469-477.
66. Guitteny AF, Fouque B, Teole R, Bloch B: Vasopressin gene expression in the normal and Brattleboro rat: A histological analysis in semi-thin sections with biotinylated probes. J Histochem Cytochem 1989;37:1479-1487.